SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-006428
Filing Date
2024-03-04
Accepted
2024-03-04 16:33:34
Documents
15
Period of Report
2023-12-27
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A ctdh20240304_8ka.htm   iXBRL 8-K/A 28740
  Complete submission text file 0001437749-24-006428.txt   179991

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231227.xsd EX-101.SCH 3850
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231227_def.xml EX-101.DEF 13750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231227_lab.xml EX-101.LAB 18060
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231227_pre.xml EX-101.PRE 13782
16 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20240304_8ka_htm.xml XML 4821
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39780 | Film No.: 24715357
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)